Q1 2024 Holdings
Filed 2024-05-15 | 66 holdings | $3.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $1.7M | 40,137 | 0.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $2.1M | 316,000 | 0.1% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $2.1M | 303,716 | 0.1% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.6M | 579,674 | 0.1% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $4.4M | 828,485 | 0.1% |
| Metagenomi Inc(MGX) | COM | 59102M104 | $4.9M | 466,232 | 0.1% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $5.4M | 1,594,931 | 0.2% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $5.8M | 1,240,034 | 0.2% |
| Aligos Therapeutics Inc | COM | 01626L105 | $6.0M | 6,102,770 | 0.2% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $6.3M | 5,000,000 | 0.2% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $6.5M | 2,523,000 | 0.2% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $7.8M | 167,784 | 0.2% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $9.2M | 600,000 | 0.3% |
| Regulus Therapeutics Inc(RGLS) | COM | 75915K309 | $9.4M | 3,266,566 | 0.3% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $11.9M | 529,452 | 0.3% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $12.1M | 680,000 | 0.3% |
| Intra-Cellular Therapies Inc(ITCIEUR)Put | COM | 46116X101 | $12.1M | 175,400 | 0.3% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $12.6M | 2,684,344 | 0.4% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $13.8M | 1,000,000 | 0.4% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $15.9M | 493,352 | 0.5% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $17.2M | 18,400,000 | 0.5% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $17.8M | 4,184,100 | 0.5% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $18.4M | 31,697,539 | 0.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $20.6M | 274,512 | 0.6% |
| Alector Inc(ALEC) | COM | 014442107 | $22.7M | 3,769,386 | 0.7% |
| Cybin Inc(CYBNEUR) | COM | 23256X100 | $24.0M | 58,139,535 | 0.7% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $26.3M | 7,000,000 | 0.8% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $35.5M | 1,643,881 | 1.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $36.5M | 3,225,419 | 1.0% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $36.5M | 1,595,400 | 1.0% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $38.1M | 2,250,000 | 1.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $40.0M | 6,100,000 | 1.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $40.9M | 5,572,607 | 1.2% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $41.0M | 5,527,290 | 1.2% |
| Hillevax Inc | COM | 43157M102 | $42.8M | 2,572,460 | 1.2% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $44.1M | 2,997,830 | 1.3% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $46.0M | 1,213,420 | 1.3% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $48.6M | 10,953,937 | 1.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $50.7M | 1,262,246 | 1.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $51.3M | 3,187,415 | 1.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $56.8M | 7,370,000 | 1.6% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $56.8M | 822,001 | 1.6% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $58.8M | 1,000,000 | 1.7% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $59.5M | 1,373,475 | 1.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $60.5M | 3,456,053 | 1.7% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $61.5M | 4,297,438 | 1.8% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $62.7M | 6,666,667 | 1.8% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $85.7M | 5,750,000 | 2.5% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $86.9M | 3,490,506 | 2.5% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $94.7M | 3,500,000 | 2.7% |